dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Van Cutsem, Eric |
dc.contributor.author | Tempero, Margaret A. |
dc.contributor.author | Sigal, Darren |
dc.contributor.author | Fazio, Nicola |
dc.contributor.author | Macarulla Mercadé, Teresa |
dc.contributor.author | Oh, Do-Youn |
dc.date.accessioned | 2021-10-22T11:45:53Z |
dc.date.available | 2021-10-22T11:45:53Z |
dc.date.issued | 2020-09-20 |
dc.identifier.citation | Van Cutsem E, Tempero MA, Sigal D, Oh DY, Fazio N, Macarulla T, et al. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma. J Clin Oncol. 2020 Sep 20;38(27):3185–94. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/6453 |
dc.description | Adenocarcinoma pancreàtic; Paclitaxel |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;38(27) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Càncer - Quimioteràpia |
dc.subject | Metàstasi |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.title | Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.20.00590 |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.relation.publishversion | https://doi.org/10.1200/JCO.20.00590 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Van Cutsem E] Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. [Tempero MA] Division of Hematology and Oncology, Department of Medicine, UCSF Medical Center, San Francisco, CA. [Sigal D] Division of Hematology/Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA. [Oh DY] Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. [Fazio N] Division of Gastrointestinal Medical Oncology & Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 32706635 |
dc.identifier.wos | 000574579100009 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |